An important randomized controlled clinical trial showed that vitamin E was associated with improved histological features including hepatic steatosis and lobular inflammation and reduced biochemical markers such as ALT and AST, but not with improvement in fibrosis, in patients with NASH (45). This evidence concerns the gene GPT and Hepatic steatosis.